DCLRE1B as a novel prognostic biomarker associated with immune infiltration: a pancancer analysis

DCLRE1B as a novel prognostic biomarker associated with immune infiltration: a pancancer analysis

Abstract The DNA cross-link repair 1B (DCLRE1B) gene is involved in repairing cross-links between DNA strands, including those associated with Hoyeraal–Hreidarsson syndrome and congenital dyskeratosis. However, its role in tumours is not well understood. DCLRE1B expression profiles were examined in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mi Zou, Zuxi Feng, Kaibo Hu, Yuan Shu, Ting Li, Xiaogang Peng, Leifeng Chen, Leyang Xiao, Shouhua Zhang, Ting Xiong, Xueqiang Deng, Jie Peng, Liang Hao
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-12-01
Series:	Scientific Reports
Subjects:	DCLRE1B Pancancer Prognostic biomarker Immunotherapy response Prognosis
Online Access:	https://doi.org/10.1038/s41598-024-80603-y
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identification of SETD4 as an Onco‐Immunological Biomarker Encompassing the Tumor Microenvironment, Prognoses, and Therapeutic Responses in Various Human Cancers
by: Yuyun Zhong, et al.
Published: (2025-01-01)

Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC
by: Haotian Qin, et al.
Published: (2025-01-01)

Prognostic Factors Predicting Remission Following Rituximab Therapy for Pemphigus Vulgaris
by: Tal Raviv, et al.
Published: (2025-01-01)

Construction of a prognostic model for gastric cancer based on immune infiltration and microenvironment, and exploration of MEF2C gene function
by: Si-yu Wang, et al.
Published: (2025-01-01)

TMEM101 expression and its impact on immune cell infiltration and prognosis in hepatocellular carcinoma
by: Lingyun Kuang, et al.
Published: (2024-12-01)

A Narrative Review of Prognostic Gene Signatures in Oral Squamous Cell Carcinoma Using LASSO Cox Regression
by: Nur Fatinazwa Mohd Faizal, et al.
Published: (2025-01-01)

SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer
by: Linyan Ge, et al.
Published: (2025-01-01)

TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma
by: Feiming Hu, et al.
Published: (2025-01-01)

Comprehensive analysis of α2,3-sialyltransferases as prognostic biomarkers and immunotherapy targets in kidney renal clear cell carcinoma
by: Yuli Jian, et al.
Published: (2025-02-01)

Prognostic signature based on mitochondria- and angiogenesis-related genes associated with immune microenvironment of multiple myeloma
by: Dai Zhang, et al.
Published: (2025-12-01)

Construction and evaluation of a prognostic model for cervical cancer based on dynamic hematological and clinical features
by: Huangrong Ma, et al.
Published: (2025-02-01)

Prognostic Models of Primary Sclerosing Cholangitis
by: A. I. Dolgushina, et al.
Published: (2023-02-01)

NIPAL1 as a prognostic biomarker associated with pancreatic adenocarcinoma progression and immune infiltration
by: Youlong Zhu, et al.
Published: (2025-01-01)

CHST1 as a prognostic-related biomarker in gastric cancer correlating with immune infiltration
by: Long Gui, et al.
Published: (2025-02-01)

Development and functional validation of a disulfidoptosis-related gene prognostic model for lung adenocarcinoma based on bioinformatics and experimental validation
by: Tao Shen, et al.
Published: (2025-02-01)

Integration of single-cell transcriptomics and bulk transcriptomics to explore prognostic and immunotherapeutic characteristics of nucleotide metabolism in lung adenocarcinoma
by: Kai Zhang, et al.
Published: (2025-01-01)

Identification and validation of BATF as a prognostic biomarker and regulator of immune cell infiltration in acute myeloid leukemia
by: Zhe Zhao, et al.
Published: (2025-01-01)

Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer
by: Shuo-Fu Chen, et al.
Published: (2024-09-01)

Development and validation of a prognostic signature of breast cancer based on drug absorption, distribution, metabolism and excretion (ADME)-related genes
by: Zhixuan Wu, et al.
Published: (2024-09-01)

Integrated analysis of M2 macrophage-related gene prognostic model and single-cell sequence to predict immunotherapy response in lung adenocarcinoma
by: Meifang Li, et al.
Published: (2025-02-01)

Inflammatory burden index as a prognostic marker in patients with advanced gastric cancer treated with neoadjuvant chemotherapy and immunotherapy
by: Jiao-Bao Huang, et al.
Published: (2025-01-01)

Prognostic value of albumin-bilirubin grade in patients with cholangiocarcinoma: a systematic review and meta-analysis
by: Mahyaar Omouri-Kharashtomi, et al.
Published: (2025-01-01)

A novel necroptosis-related gene signature predicts the prognosis and immunotherapeutic response in breast cancer through immune infiltration
by: Dezhi Lu, et al.
Published: (2025-01-01)

CTSG is a prognostic marker involved in immune infiltration and inhibits tumor progression though the MAPK signaling pathway in non-small cell lung cancer
by: Qian Dai, et al.
Published: (2024-12-01)

The lysosome-related characteristics affects the prognosis and tumor microenvironment of lung adenocarcinoma
by: Wuguang Chang, et al.
Published: (2025-01-01)

NT5E (CD73) as a prognostic biomarker and therapeutic target associated with immune infiltration in lung adenocarcinoma
by: Leyan Chen, et al.
Published: (2025-02-01)

Biomarkers in Nasopharyngeal Carcinoma (NPC): Clinical relevance and prognostic potential
by: Madhan Krishnan, et al.
Published: (2024-09-01)

Multiple machine learning-based integrations of multi-omics data to identify molecular subtypes and construct a prognostic model for HNSCC
by: Xiaoqin Luo, et al.
Published: (2025-02-01)

The value of biomarkers in the diagnosis and prognostic analysis of IgA nephropathy
by: Lu Min, et al.
Published: (2025-01-01)

Interleukin-6 as a Pan-Cancer Prognostic Inflammatory Biomarker: A Population-Based Study and Comprehensive Bioinformatics Analysis
by: Xie H, et al.
Published: (2025-01-01)

RBM47 is a novel immunotherapeutic target and prognostic biomarker in gliomas
by: Wei Wei, et al.
Published: (2025-01-01)

A study of specific immunoglobulin G4 expression in allergic rhinitis and its value in assessing efficacy and in predicting prognosis of sublingual immunotherapy
by: Ting‐Ting Wei, et al.
Published: (2025-01-01)

Integrated bioinformatics and experimental analysis of CHAF1B as a novel biomarker and immunotherapy target in LUAD
by: Wei Du, et al.
Published: (2025-01-01)

An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers
by: Ruyi Liu, et al.
Published: (2025-02-01)

The age-adjusted international prognostic index 2 (A-FLIPI2) for elderly patients with follicular lymphoma
by: Jiesong Wang, et al.
Published: (2025-02-01)

Elevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer
by: L. S. Franco, et al.
Published: (2025-01-01)

NOS2 as a prognostic biomarker for early-onset colorectal cancer based on public data and clinical validation analysis
by: Chaoqun Xing, et al.
Published: (2025-02-01)

Progress in immune microenvironment, immunotherapy and prognostic biomarkers in pediatric osteosarcoma
by: Lin Zhang, et al.
Published: (2025-01-01)

GNA15 predicts poor outcomes as a novel biomarker related to M2 macrophage infiltration in ovarian cancer
by: Qin Liu, et al.
Published: (2025-02-01)

Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications
by: Yating Cong, et al.
Published: (2025-01-01)